New Nanoparticle Carriers Designed to Penetrate the Blood-Brain Barrier
Scientists are engineering tiny particles capable of ferrying large therapeutic molecules across the blood-brain barrier, which normally blocks such substances.
The brain’s protective shield, the blood-brain barrier, allows only limited chemicals to cross, safeguarding neural tissue from toxins and pathogens. Consequently, larger therapeutic agents such as proteins and messenger RNA are effectively excluded, hindering treatment of serious neurological disorders. Recent research focuses on designing microscopic particles that can encapsulate these large molecules and traverse the barrier.
By mimicking or temporarily opening the barrier’s tight junctions, these carriers could deliver drugs directly to brain tissue. The strategy seeks to balance the barrier’s essential protective function with the need for effective drug delivery, potentially transforming treatment options for conditions that have been difficult to address.
Why it matters
It could enable medicines to reach the brain, opening new options for treating neurological diseases.
In this story
